SynthesisHuman vaccines & immunotherapeutics2025
Systematic literature review and meta-analysis on the prevalence of rotavirus genotypes in Asia from 2015 to 2021.
Synthesis in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- Prevalence of sapovirus infection among hospitalized pediatric patients in Asia: A systematic review and meta-analysis.World journal of virology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Understanding rotavirus prevalence by genotype can inform disease prevention and immunization decision-making. This systematic literature review summarized the genotype-specific prevalence of rotavirus in Asia from 2015 to 2021. We identified surveillance studies using PubMed, Embase, and Scopus databases, and used proportional meta-analysis (with the generic inverse variance method with arcsine transformation and generalized linear mixed models) to summarize genotype prevalence by region. A total of 7,601 studies were screened, and 73 studies from 16 countries were included. Data from 19,935 rotavirus samples reveal that the most common rotavirus genotypes circulating in Asia from 2015 to 2021 were G3P[8] (24%; 95% CI: 19%, 30%), G9P[8] (11%; 95% CI: 7%, 16%), G1P[8] (11%; 95% CI: 8%, 14%) and G2P[4] (8%; 95% CI: 6%, 10%). The results are comparable to estimates from the pre-vaccine licensure period. Surveillance based on sequencing data could help detect more subtle changes and further characterize the rotavirus burden in Asia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.